Dr. Tom Keelin

Dr. Tom Keelin
- Designation: Founder, SDG | Adjunct, Stanford University

Dr. Tom Keelin serves as Managing Partner at Keelin Reeds Partners, LLC. Dr. Keelin has supervised portfolio management, asset strategy and valuation, or deal terms assessment and negotiations projects for more than 30 emerging growth life sciences companies.

He serves as Chairman and Director of Strategic Decisions Group (SDG). Dr. Keelin serves as Member of Board of Advisors of Grow Talent Company Ltd. To support emerging-biotech decisions about when to partner and under what terms, he supervised a joint effort between KR and the Biotechnology Industry Organization (BIO) to develop, benchmark, and validate a way to estimate asset-specific deal terms based on the asset-specific economic characteristics and relative strength of negotiating position of the parties. In parallel, he invented, tested, and authored a patent application on an innovative R&D productivity simulation method which uniquely highlights improved portfolio management approaches that may more than double R&D productivity for some companies.

He has led business and product strategy efforts for many Global 1000 companies He also pioneered and helped them implement their adopted methods for asset valuation and portfolio management

PGDM Batch 2025-27 Orientation Start Date - 20^th June 2025

Media

Campus

Annual Events

Accreditations &
Associations

Research & Publications

Conferences

Awards & Achievements

Dr. Tom Keelin

PGDM Batch 2025-27 Orientation Start Date - 20th June 2025

PGDM Batch 2025-27 Orientation Start Date - 20^th June 2025